Skip to main content

Table 5 Overall and subgroups meta-analysis of COX-2 rs20417 polymorphism and HNSCC risk

From: COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data

Overall and subgroups

No.

OR (95 % CI)

Heterogeneity (I2%/p)

C vs. G (unadjusted and adjusted)

 Overall (unadjusted)

5

1.13 (0.62–2.05)

92 %/<0.10

 OSCC (unadjusted)

4

1.22 (0.52–2.89)

94 %/<0.10

 OSCC (adjusted)

1

0.73 (0.50–1.08)

NA

 Asians (unadjusted)

4

1.22 (0.52–2.89)

94 %/<0.10

 Caucasian (unadjusted)

1

0.92 (0.70–1.21)

NA

 HWE (Yes–unadjusted)

4

0.78 (0.52–1.18)

83 %/<0.10

 HWE (No–unadjusted)

1

6.08 (3.03–12.22)

NA

CC vs. GG (unadjusted and adjusted)

 Overall (unadjusted)

5

1.17 (0.25–5.46)

80 %/<0.10

 Overall (adjusted)

2

0.53 (0.25–1.11)

0 %/0.71

 OSCC (unadjusted)

4

1.79 (0.10–31.00)

89 %/<0.10

 OSCC (adjusted)

1

0.44 (0.13–1.46)

NA

 Asians (unadjusted)

4

1.79 (0.10–31.00)

89 %/<0.10

 Caucasian (unadjusted)

1

0.62 (0.25–1.50)

NA

 HWE (Yes–unadjusted)

4

0.55 (0.27–1.13)

0 %/0.67

 HWE (No–unadjusted)

1

7.75 (1.70–35.33)

NA

GC vs. GG (unadjusted and adjusted)

 Overall (unadjusted)

5

0.69 (0.36–1.35)

0 %/0.75

 Overall (adjusted)

2

0.90 (0.68–1.19)

9 %/0.29

 OSCC (unadjusted)

4

0.80 (0.30–2.09)

0 %/0.50

 OSCC (adjusted)

1

0.71 (0.42–1.18)

NA

 Asians (unadjusted)

4

0.80 (0.30–2.09)

0 %/0.50

 Caucasian (unadjusted)

1

0.62 (0.24–1.55)

NA

 HWE (Yes–unadjusted)

4

0.62 (0.30–1.29)

0 %/0.98

 HWE (No–unadjusted)

1

1.29 (0.23–7.31)

NA

CC vs. CG + GG (unadjusted)

 Overall

5

1.15 (0.29–4.54)

76 %/0.02

 OSCC

4

1.76 (0.15–21.30)

85 %/<0.10

 Asians

4

1.76 (0.15–21.30)

85 %/<0.10

 Caucasian

1

0.62 (0.25–1.50)

NA

 HWE (Yes)

4

0.58 (0.29–1.18)

0 %/0.84

 HWE (No)

1

6.43 (1.41–29.27)

NA

CC + CG vs. GG (unadjusted and adjusted)

 Overall (unadjusted)

5

1.07 (0.51–2.24)

93 %/<0.10

 OSCC (unadjusted)

4

1.13 (0.39–3.26)

95 %/<0.10

 OSCC (adjusted)

1

0.22 (0.12–0.39)

NA

 Asians (unadjusted)

4

1.13 (0.39–3.26)

95 %/<0.10

 Caucasian (unadjusted)

1

0.90 (0.70–1.30)

NA

 HWE (Yes–unadjusted)

4

0.72 (0.39–1.33)

90 %/<0.10

 HWE (No–unadjusted)

1

6.45 (2.90–14.35)

NA

  1. OSCC oral squamous cell carcinoma; HNSCC head and neck squamous cell carcinoma; LSCC laryngeal squamous cell carcinoma; OR odds ratio; CI confidence interval; NA not available; HWE Hardy–Weinberg Equilibrium